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The two chalcones xanthoangelol (XA) and 4-hydroxyderricin (4HD) are major functional polyphenolic com-
pounds in the edible herb Angelica keiskei, which is native to Japan. The compounds XA and 4HD are known to have
anti-inflammatory and anti-diabetic functions although their beneficial effect on vascular disease is not clear. Athero-
sclerosis induced by lifestyle-related diseases such as obesity and hypertension is a serious vascular disease in which
endothelial injury plays a major pathogenic role. Therefore, the healing of endothelial injury is considered important
in preventing atherosclerosis. The present study examined whether XA and 4HD promote the wound healing of
cultured porcine vascular endothelial cells (ECs) and analyzed the molecular mechanisms of their effect. Both com-
pounds promoted endothelial wound healing, induced nitric oxide (NO) production, and increased heme oxygenase-1
(HO-1) expression as well as the phosphorylation level of endothelial NO synthase (eNOS). The wound healing
promoted by these compounds was inhibited by pretreatment with the NOS inhibitor L-NMMA and HO-1 inhibitor
ZnPPIX, respectively. ZnPPIX inhibited the phosphorylation of eNOS as well. XA- and 4HD-dependent wound
healing was also blocked by hemoglobin, a carbon monoxide (CO) absorbent. A CO-releasing molecule facilitated the
wound healing, which was suppressed by pretreatment with L-NMMA. These results suggest that XA and 4HD stimu-
late wound healing by increasing HO-1 expression with subsequent CO production, which activates eNOS followed by
NO generation. Our findings indicate that the two chalcones in Angelica keiskeimay have a preventative effect against
atherosclerosis.
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Introduction
The two chalcones xanthoangelol (XA) and 4-
hydroxyderricin (4HD) are major functional polyphe-
nolic compounds in the edible herb Angelica keiskei,
which is native to Japan. These two compounds are
known to have various beneficial effects. They exhibit
antihypertensive, anticancer, and diuretic effects
(Enoki et al., 2007; Kimura and Baba, 2003; Kimura,
2005; Motani et al., 2008). The compounds also have
a suppressive effect on blood glucose level (Shimizu et
al., 1999; Matsuura et al., 2001), an antiulcer effect
and an inhibitory effect on gastric secretion (Murakami
et al., 1990), a beneficial effect on lipid metabolism
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(Ogawa et al., 2007), and an antibacterial effect
(Inamori et al., 1991). However, their effect on pre-
venting atherosclerosis is not clear. Accumulating evi-
dence demonstrates that other polyphenolic com-
pounds, such as resveratrol in red wine and epigal-
locatechin gallate in green tea, are effective in pre-
venting atherosclerosis (Iijima et al., 2000; Iijima et
al., 2002; Miura et al., 2001; Lorenz et al., 2004).
Especially, resveratrol is believed to play a role in the
unexpectedly low rates of heart disease and associated
mortality in France, where a typical diet including
dairy product and meat has a high fat content. Res-
veratrol has a number of beneficial effects, including
protection of the endothelium from oxidized low-
density lipoprotein (Ou et al., 2006), and anticancer
and neuroprotective effects (Brisdelli et al., 2009).
Epigallocatechin gallate was demonstrated to promote
nitric oxide (NO) generation followed by vasodilation
(Lorenz et al., 2004) and to prevent atherosclerosis in a
mouse model (Miura et al., 2001).
Heart disease and cerebrovascular disease are major
causes of death and account for approximately 25% of
mortality in Japan. These diseases are caused by ath-
erosclerosis, which is induced by lifestyle-related dis-
ease called metabolic syndrome such as obesity, dia-
betes, and hypertension. Metabolic syndrome is linked
to the increase in reactive oxygen species (ROS)
levels, which lead to endothelial injury. Monocytes
and T-lymphocytes adhere to the injuries, eventually
creating atheromas which result in vascular occlusion.
Endothelial cells (ECs) adjacent to the wound repair
the wounded area through the migration and/or pro-
liferation of these cells. Since the delay in wound
healing causes thrombus formation and vascular hyper-
permeability leading to atherosclerosis, endothelial
wound repair is a fundamental step in the prevention of
atherosclerosis.
A number of endogenous molecules are involved in
endothelial wound healing. NO generated by endothe-
lial NO synthase (eNOS) acts as an endothelium-
derived relaxing factor. NO also contributes to the
proliferation and migration of ECs, and elicits cyto-
protective and atheroprotective effects in the vas-
culature (Cooke, 2003; Gewaltig, 2002; Kibbe et al.,
1999). Kuhlencordt et al. (2001) demonstrated that
endothelial NO suppresses atherosclerosis and that
atherosclerosis progresses rapidly in eNOS-knockout
mice. Thus, regulating NO production is considered
pivotal for endothelial wound healing. Heme oxy-
genase-1 (HO-1) is an enzyme that catabolizes heme
and biliverdin into carbon monoxide (CO) and free
iron. CO generated by HO-1 was indicated to phos-
phorylate eNOS and prevent hypertension via NO
production (Wegiel et al., 2010; Zuckerbraun et al.,
2006; Rodella et al., 2008).
In the present study, we aimed to evaluate the effect
of XA and 4HD on endothelial wound healing, and to
investigate the molecular mechanism of this effect,
focusing on NO, eNOS, and HO-1.
Materials and Methods
1. Materials
Mixture of chalcones was perchased from Japan Bio
Science Laboratory CO.,Ltd. and XA and 4HD were
purified from the mixture in our laboratory. Hydroxy-
tyrosol (HT) was purchased from Cayman Chemical
Co. (Ann Arbor, MI, USA). Lysophospatidic acid
(LPA), Carbon monoxide-releasing molecules (CORM),
N
G
-methyl-L-arginine acetate salt (L-NMMA) and
hemoglobin were purchased from Sigma-Aldrich
(Missouri, USA). Zinc (II) Protoporphyrin IX (ZnPPIX)
was perchased from Merck Millipore (Darmstadt,
Germany).
2. Cell culture
ECs were isolated from porcine pulmonary arteries
and grown in Dulbecco's modified Eagle’s medium
(DMEM) at 37℃ in a humidified 5% CO2 incubator.
The DMEM containing low glucose was supplemented
with 10% fetal bovine serum (FBS), 100U/ml peni-
cillin, and 100 μg/ml streptomycin. ECs were ana-
lyzed between passages six to ten.
3. Wound-healing assay
ECs were seeded onto 3.5-cm plates at a density of
3×10
5
cells/plate and incubated for 7 h with DMEM
containing 10% FBS. Cell culture medium was then
replaced with DMEM containing 1% FBS and the ECs
were incubated for another 16 h. Then the ECs were
treated with test substances (4HD, XA, and CORM)
and positive control (LPA). In wound-healing assays
with inhibitors, L-NMMA, ZnPPIX or hemoglobin
was applied 1 h before the addition of test substances
and positive control. A wound was then created by
scratching the monolayer of confluent, serum-starved
ECs with a 200-μl pipette tip. The scratch area was
imaged using an inverted microscope attached to a
digital camera (Leica DM IBRE) immediately (0 h)
and at 8 and 24 h after wound creation. The plate was
incubated at 37℃ from wound creation to the 8- and
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24-h. Three microscopic fields were selected at ran-
dom from the microscopic images at each time, and the
number of cells in the fields was counted. Wound
healing (%) was calculated as the value for each test
substance or positive control versus the control valued
at each time.
4. NO production assay
NO production was measured by fluorometric
detection using DAF-2 DA, a cell-permeable and NO-
sensitive fluorescent dye. ECs were seeded onto a 96-
well plate (at 6×10
3
cells/well) and incubated with 10
μM DAF-2 DA in a dark condition for 45min at 37℃.
After washing the ECs with Hank’s balanced salt
solution (HBSS), NO production was stimulated by the
addition of HBSS containing 4HD, XA or HT. Fluo-
rescence intensities were measured using a spectro-
fluorophotometer (Powerscan HT, Dainippon Pharma-
ceutical, Tokyo, Japan) at excitation and emission
wavelengths of 485 and 535 nm, respectively, after 1,
3, 6, and 12 h of treatment.
5. Western blot analysis
ECs were seeded onto 3.5-cm plates at a density of
2×10
5
cells/plate, and incubated for 7 h with DMEM
containing 10% FBS. Cell culture medium was then
replaced with DMEM containing 1% FBS and the cells
were incubated for 16 h. After required treatment, ECs
were washed twice with ice-cold PBS and suspended
in a lysis buffer containing 50% glycerol, 100mM
NaF, 10mM sodium pyrophosphate, 1% Triton X-
100, 1mM Na3 VO4, 1mM phenylmethylsulfonyl
fluoride (PMSF), 10 μg/mL antipain, 10 μg/mL leu-
peptin, and 10 μg/mL aprotinin. Lysates were sepa-
rated by centrifugation at 17,900 g for 15min at 4℃
and used for the experiment. Equal amounts of pro-
teins per sample were separated by 10% sodium do-
decyl sulfate polyacrylamide gel electrophoresis and
transferred to polyvinylidene difluoride membranes.
Membranes were then blocked with 5% non-fat dried
milk or 5% BSA/TBS-T at room temperature and sub-
sequently incubated overnight with antibodies at 4℃.
Thereafter, blots were incubated with secondary
antibodies at room temperature. Bands were detected
using a Western Lightning
TM
Chemiluminescence Kit
(Life Technologies Corporation, Santa Cruz, CA, USA)
in accordance with the manufacturer's instructions.
The intensity of each band was quantified using a
LAS-4000 imaging mini analyzer (Fujifilm, Tokyo,
Japan).
6. Statistical analysis
Data are expressed as mean values (±S.D.) for at
least three independent experiments. Differences be-
tween treatments were analyzed using Student’ s t-
test. P values less than 0.05 were considered statisti-
cally significant.
Results
1. 4HD and XA promote endothelial wound healing.
We evaluated the effect of 4HD and XA on endothelial
wound healing at 8 and 24 h after wound creation. The
wound healing at both 8 h and 24 h was maximally
promoted by 4HD and XA at a concentration of 1 μM
(Fig. 1). 4HD tended to be more effective than XA in
repairing the wound.
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Fig. 1. 4HD and XA promote endothelial wound
healing. Wound healing was determined 8 h (A) and 24
h (B) after wound creation in the presence and absence
of the treatment of LPA, 4HD, and XA. LPA was
used as a positive control. * p＜0.05 vs. Cont.
2. 4HD and XA increase endothelial NO production.
We evaluated the effect of 4HD and XA on endo-
thelial NO production to investigate the mechanism for
their promotion of wound healing. 4HD and XA time-
dependently increased endothelial NO production at all
tested concentrations (0.1, 0.3, and 1.0 μM) respective-
ly, except for 0.1 μMXA (Fig. 2). The NO production
level of 4HD tended to be more effective than XA.
We used 4HD and XA at 1 μM for subsequent experi-
ments, because the highest NO production was ob-
tained at 1 μM.
3. 4HD and XA activates eNOS.
We evaluated the phosphorylation level of eNOS in
4HD- and XA-treated ECs to investigate whether the
two chalcones activate eNOS. We targeted phos-
phorylation of eNOS at serine 1177 (Ser1177) because
Ser1177 is one of the activation sites (Kukreja and Xi,
2007; Mount et al., 2007) and phosphorylated by
various kinases including Akt, protein kinase A, and
AMP-activated kinase (Fulton et al., 1999). Phos-
phorylated eNOS (Ser1177) level increased time-
dependently from 3 h after addition of 4HD and from 6
h after addition of XA (Fig. 3). This effect of pro-
longed chalcone treatment on eNOS activation is
consistent with the result of NO production shown in
Fig. 2, suggesting that 4HD- and XA-induced NO pro-
duction is linked to eNOS activation.
4. NO mediates 4HD- and XA-stimulated endothelial
wound healing.
We investigated the effect of the NO inhibitor L-
NMMA on 4HD- and XA-dependent wound healing.
Pretreatment of ECs with 1 mM L-NMMA suppressed
the wound healing promoted by 4HD and XA (Fig. 4),
indicating that NO production mediates chalcone-
enhanced endothelial wound healing.
5. 4HD and XA increase endothelial HO-1 protein
expression.
We investigated HO-1 protein expression levels in
4HD- and XA-treated ECs to evaluate the role of HO-
1 in chalcone-enhanced endothelial wound healing.
HO-1 protein expression level increased time-depend-
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Fig. 3. 4HD and XA activate eNOS. Phosphorylated eNOS (p-eNOS) (Ser1177) levels in ECs were de-
termined by western blotting after treatment with 4HD or XA for 0, 3, 6, 12, and 24 h. α-Tubulin was
used as the internal standard.
Fig. 2. 4HD and XA increase endothelial NO produc-
tion. NO was quantified at 1, 3, 6, and 12 h after addi-
tion of 4HD (A) or XA (B). HT was used as the posi-
tive control.
ently from 3 h after addition of 4HD and from 6 h after
addition of XA (Fig. 5), suggesting that HO-1 is likely
to be involved in the promotion of wound healing by
these chalcones.
6. HO-1 is involved in 4HD- and XA-dependent endo-
thelial wound healing and eNOS phosphorylation.
We examined the effect of the HO-1 inhibitor
ZnPPIX on 4HD- and XA-induced wound healing.
Pretreatment of ECs with ZnPPIX inhibited wound
healing (Fig. 6A). We also evaluated phosphorylated
eNOS levels in 4HD- and XA-treated ECs after pret-
reatment with ZnPPIX. The inhibitor suppressed
chalcone-induced eNOS phosphorylation (Fig. 6B).
These data suggest that HO-1 is critically implicated in
4HD- and XA-stimulated endothelial wound healing
by activating eNOS.
7. HO-1-dependent generation of CO activates eNOS.
We investigated the effect of CORM, a CO-releas-
ing molecule, on wound healing to know whether HO-
1-induced generation of CO plays an important role in
wound healing. CORM promoted wound healing in a
dose-dependent manner at 8 and 24 h after wound crea-
tion (Fig. 7). The eNOS inhibitor L-NMMA suppres-
sed CORM-dependent wound healing (Fig. 8). hemo-
globin (Hb), a CO absorbent, inhibited 4HD- and XA-
related wound healing (Fig. 9). These data suggest
that HO-1-dependent production of CO critically con-
tributes to the wound healing induced by these chal-
cones through eNOS activation.
Discussion
In the present study, we investigated the effect of the
chalcones 4HD and XA on endothelial wound healing.
We found that both chalcones promote the wound
healing of cultured ECs by increasing the expression of
HO-1, which generates CO followed by the activation
of eNOS with subsequent NO production.
The dysfunction of ECs induced by various stresses
including oxidative stress is critically implicated in the
initiation and progression of atherosclerosis. There-
fore, the compounds that promote endothelial wound
healing are strong candidates for anti-atherogenic
factors. We have already found more than ten such
candidates. They include resveratrol and its dimer ε-
viniferin in red wine (Zghonda et al., 2011), HT in
olive oil (Zrelli et al., 2011), carnosic acid in rose-
mary, and caffeoylquinic acid and chlorogenic acid in
coffee. All of them are polyphenolic compounds and
generate NO by activating eNOS, which is consistent
with the present data of the chalcones. Interestingly,
resveratrol, ε-viniferin, HT, carnosic acid raised HO-1
expression as 4HD and XA whereas caffeoylquinic
acid and chlorogenic acid did not, suggesting that
eNOS activation mechanism may be different, de-
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Fig. 5. 4HD and XA increase endothelial HO-1 protein expression. HO-1 expression levels in ECs
were determined by western blotting analysis after treatment with 4HD or XA for 0, 3, 6, 12, and 24 h.
α-Tubulin was used as the internal standard.
Fig. 4. NO mediates 4HD- and XA-promoted endo-
thelial wound healing. Wound healing was deter-
mined 8 h after wound creation for LPA, 4HD, and
XA-treated cells with and without pretreatment with
1mM L-NMMA. * p＜0.05 vs. Cont (−);
#
p＜0.05 vs.
4HD(−) or XA(−).
pending on the polyphenolic compound (data not
shown).
Our data demonstrate that 4HD- and XA-dependent
increase in HO-1 expression and phosphorylation level
of eNOS with subsequent NO production is sustained.
In contrast, although acetylcholine induces vasore-
laxation by activating eNOS followed by NO pro-
duction via the PI3 kinase/Akt signaling pathway, this
effect is short-lived (Zecchin et al., 2007; Seto et al.,
2010). We consider that natural polyphenolic com-
pounds including 4HD and XA obtained from normal
dietary may be more effective in sustaining endothelial
wound healing and NO generation than endogenous
substances such as acetylcholine. In agreement with
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Fig. 6. HO-1 is involved in 4HD- and XA-dependent endothelial wound healing and eNOS phosphor-
ylation. (A) Wound healing was determined 8 h after wound creation for 4HD- and XA-treated ECs with
and without pretreatment with 1 µM ZnPPIX. * p＜0.05 vs. Cont(−),
#
p＜0.05 vs. 4HD(−) or XA(−).
(B) p-eNOS (Ser1177) levels in ECs were determined by western blotting after treatment with 4HD or
XA for 5 h with and without pretreatment with 1 μM ZnPPIX.
our thought, there are many reports indicating that
natural polyphenolic compounds including 4HD and
XA reduce blood pressure (Ogawa et al., 2005;
Zghonda et al., 20112).
Conclusions
We investigated two chalcones, 4HD and XA, for
their potential to promote wound healing. These chal-
cones are present in the edible herb Angelica keiskei.
The prevention of various diseases through diet has
received much attention recently. Prompt healing of
endothelial injury is important for the prevention of
atherosclerosis. 4HD and XA are known to have some
beneficial health effects, but their efficacy against
atherosclerosis is still unclear. Therefore, the present
study aimed to elucidate the effects of 4HD and XA on
in vitro endothelial wound healing and understand the
molecular mechanism of their effects.
We found that the chalcones 4HD and XA promote
wound healing by increasing HO-1 expression with
subsequent CO production, which activates eNOS fol-
lowed by NO generation. Our findings suggest that
these two chalcones in Angelica keiskei may have a
preventative effect against atherosclerosis.
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Fig. 7. CORM promotes endothelial wound healing.
Wound healing was determined 8 h (A) and 24 h (B)
after wound creation for LPA- and CORM-treated
cells. LPA was used as a positive control. * p＜0.05 vs.
Cont.
Fig. 8. L-NMMA suppresses CORM-dependent wound
healing. Wound healing was determined 8 h after
wound creation for CORM (50 μM)-treated ECs with
and without pretreatment with 1mM L-NMMA. * p＜
0.05 vs. Cont(−),
#
p＜0.05 vs CORM(−).
Fig. 9. Hemoglobin inhibits 4HD- and XA-depend-
ent wound healing. Wound healing was determined 8
h after wound creation for 4HD- and XA-treated ECs
with and without pretreatment with 10 μM Hb. * p＜
0.05 vs. Cont(−),
#
p＜0.05 vs. 4HD(−) or XA(−).
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